Jonathan B Yuval1, Karry J Felix2, Jonathan Demma1, Haytem Awissat1, Asaf Kedar1, Daniel J Weiss1, Alon J Pikarsky1, Ora Paltiel2, Irena Hamdi-Levi1, Yosef Kalish3, Miklosh Bala4. 1. Trauma and Acute Care Surgery, Department of Surgery, Hadassah-Hebrew University Medical Center, Kiryat Hadassah, POB 12000, 91120, Jerusalem, Israel. 2. The Joseph H. and Belle R. Braun School of Public Health and Community Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 3. Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 4. Trauma and Acute Care Surgery, Department of Surgery, Hadassah-Hebrew University Medical Center, Kiryat Hadassah, POB 12000, 91120, Jerusalem, Israel. Rbalam@hadassah.org.il.
Abstract
PURPOSE: Oral anticoagulants (AC) and antiplatelet (AP) agents are increasingly prescribed to prevent and treat acute and chronic thrombotic conditions. The direct oral anticoagulants (DOAC), a newer class of AC, raise concerns in the trauma setting. Our study aims to compare the mortality rates and other outcomes among adult trauma patients based on pre-admission AC/AP status. METHODS: We conducted a retrospective cohort study of a prospectively collected database of trauma patients previously on DOAC, warfarin, aspirin or clopidogrel. A matched control group of trauma patients not receiving AC/AP was used for comparison. Our primary endpoint was in-hospital mortality according to antithrombotic medication class. Secondary endpoints included length of stay (LOS), intensive care unit (ICU) admission, need for blood transfusion, and discharge to a dependent setting. Univariate and multivariate analyses were conducted. RESULTS: There were 996 exposed patients and 234 controls, with no major clinically significant difference among study groups in terms of gender, injury site, injury severity, mechanism, and comorbidities. The mortality rates were 2.14% (control, 5/234), 2.88% (DOAC, 3/104), 3.34% (aspirin, 17/509), 7.63% (warfarin, 18/236), 9% (clopidogrel, 8/89), and 13.79% (aspirin + clopidogrel, 8/58) (p < 0.001). In multivariate analyses, there was no difference regarding mortality between DOAC and reference groups. Blood transfusion was more likely in patients receiving warfarin or AP than those prescribed DOAC. CONCLUSION: There was no evidence of increased mortality or blood transfusion requirement among trauma patients on DOAC, including head trauma patients. Further studies on head trauma and specific subgroups of DOAC are recommended.
PURPOSE: Oral anticoagulants (AC) and antiplatelet (AP) agents are increasingly prescribed to prevent and treat acute and chronic thrombotic conditions. The direct oral anticoagulants (DOAC), a newer class of AC, raise concerns in the trauma setting. Our study aims to compare the mortality rates and other outcomes among adult trauma patients based on pre-admission AC/AP status. METHODS: We conducted a retrospective cohort study of a prospectively collected database of trauma patients previously on DOAC, warfarin, aspirin or clopidogrel. A matched control group of trauma patients not receiving AC/AP was used for comparison. Our primary endpoint was in-hospital mortality according to antithrombotic medication class. Secondary endpoints included length of stay (LOS), intensive care unit (ICU) admission, need for blood transfusion, and discharge to a dependent setting. Univariate and multivariate analyses were conducted. RESULTS: There were 996 exposed patients and 234 controls, with no major clinically significant difference among study groups in terms of gender, injury site, injury severity, mechanism, and comorbidities. The mortality rates were 2.14% (control, 5/234), 2.88% (DOAC, 3/104), 3.34% (aspirin, 17/509), 7.63% (warfarin, 18/236), 9% (clopidogrel, 8/89), and 13.79% (aspirin + clopidogrel, 8/58) (p < 0.001). In multivariate analyses, there was no difference regarding mortality between DOAC and reference groups. Blood transfusion was more likely in patients receiving warfarin or AP than those prescribed DOAC. CONCLUSION: There was no evidence of increased mortality or blood transfusion requirement among trauma patients on DOAC, including head trauma patients. Further studies on head trauma and specific subgroups of DOAC are recommended.
Authors: Adrian A Maung; Bishwajit Bhattacharya; Kevin M Schuster; Kimberly A Davis Journal: J Trauma Acute Care Surg Date: 2016-10 Impact factor: 3.313
Authors: James M Feeney; Matthew Neulander; Monica DiFiori; Lilla Kis; David S Shapiro; Vijay Jayaraman; William T Marshall; Stephanie C Montgomery Journal: Injury Date: 2016-08-27 Impact factor: 2.586
Authors: Leslie Kobayashi; Galinos Barmparas; Patrick Bosarge; Carlos V Brown; Marko Bukur; Matthew M Carrick; Richard D Catalano; Jan Holly-Nicolas; Kenji Inaba; Stephen Kaminski; Amanda L Klein; Tammy Kopelman; Eric J Ley; Ericca M Martinez; Forrest O Moore; Jason Murry; Raminder Nirula; Douglas Paul; Jacob Quick; Omar Rivera; Martin Schreiber; Raul Coimbra Journal: J Trauma Acute Care Surg Date: 2017-05 Impact factor: 3.313
Authors: Zachary D W Dezman; Angela C Comer; Gordon S Smith; Mayur Narayan; John R Hess; Jon Mark Hirshon Journal: J Emerg Med Date: 2016-06-27 Impact factor: 1.484